ReviewJCO precision oncology2021
Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities.
Abstract readReview
In one paragraph
Review in JCO precision oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.Annals of surgical oncology · 2025Pooled it
- Optimising rare tumour risk syndromes care: clinical insights and the PREVENTABLE socioeconomic framework.European journal of human genetics : EJHG · 2026Article
- FROM DISCOVERY SCIENCE TO THE CLINIC - HERITABLE ENDOCRINE CANCERS AND RELATED DISORDERS: Functional imaging in hereditary endocrine neoplasms: evolving modalities and clinical implications.Endocrine-related cancer · 2026Review
- Redefining holistic care for gynecologic hereditary cancer syndromes through universal social work referrals.Gynecologic oncology reports · 2026Article
- Suboptimal Adherence to Hereditary Cancer Risk Management Guidelines: A Cohort Study of High-Risk Individuals in Newfoundland and Labrador, Canada.Current oncology (Toronto, Ont.) · 2026Article
- Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers ofWorld journal of oncology · 2026Review
- Optimizing Reporting and Outreach for Surveillance and Risk-Reducing Surgeries for Cancer Genetic Predisposition: Findings of a Workshop Organized by the International Cascade Consortium.Public health genomics · 2026Article
- Barriers and interventions to improve the uptake of cancer risk management strategies in hereditary cancer syndromes: a narrative review.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2026Review
- Barriers and facilitators of cancer genetic risk screening at community-based organizations serving Latinas.Journal of community genetics · 2025Article
- Association between cancer screenings uptake and genetic testing for cancer risk among US adults: findings from HINTS 2017-2020.Journal of community genetics · 2025Article
- Using a behaviour-change approach to support uptake of population genomic screening and management options for breast or prostate cancer.European journal of human genetics : EJHG · 2025Article
- Families' experiences accessing care after genomic sequencing in the pediatric cancer context: "It's just been a big juggle".Journal of genetic counseling · 2024Article
- Genomic Newborn Screening for Pediatric Cancer Predisposition Syndromes: A Holistic Approach.Cancers · 2024Review
- Intersectionality,Cancers · 2024Article
- Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study.Public health genomics · 2024Article
- Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care.Genetics in medicine : official journal of the American College of Medical Genetics · 2024Article
- Article
- Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study.Cancer medicine · 2023Article
- Development of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch Syndrome.JCO clinical cancer informatics · 2023Article
- Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Kathleen F MittendorfDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.ORCID 0000-0003-1097-9171
Sarah KnerrSchool of Public Health, University of Washington, Seattle, WA.ORCID 0000-0001-5461-6298
Tia L KauffmanDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.
Nangel M LindbergDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.
Katherine P AndersonDenver Health and Hospital Authority, Denver, CO.ORCID 0000-0001-6102-838X
Heather Spencer FeigelsonInstitute for Health Research, Kaiser Permanente, Denver, CO.ORCID 0000-0001-6691-3740
Marian J GilmoreDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.
Jessica Ezzell HunterDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.ORCID 0000-0002-1117-1097
Galen JosephDepartment of Humanities and Social Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA.
Stephanie A KraftTreuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute, Seattle, WA.ORCID 0000-0002-2862-7601
Jamilyn M ZeppDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.ORCID 0000-0002-7240-2151
Sapna SyngalDana Farber Cancer Institute, Boston, MA.
Benjamin S WilfondTreuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital and Research Institute, Seattle, WA.ORCID 0000-0002-2671-9860
Katrina A B GoddardDepartment of Translational and Applied Genomics, Center for Health Research, Kaiser Permanente Northwest, Portland, OR.
Funding
Exome sequencing in Diverse Populations in Colorado & OregonU01HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI LEO, MICHAEL C, WILFOND, BENJAMIN SIMON · 2017 to 2021
$15.7MEvolving Our Partnership: The CSER2 Centralized Support Coordinating CenterU24HG007307 · NHGRI · UNIVERSITY OF WASHINGTON · PI FULLERTON, STEPHANIE MALIA, JARVIK, GAIL PAIRITZ · 2017 to 2021
$5.8MNHGRI NIH HHS U01 HG007292NHGRI NIH HHS U24 HG007307
Abstract
PubMed holds no abstract for this paper.
Indexed as
Health Status DisparitiesRisk Reduction BehaviorSocial BehaviorHealth LiteracyHumansNeoplastic Syndromes, HereditaryProfessional-Patient RelationsSystemic Racism
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.